Summary data of potency and parameter information from semi-mechanistic PKPD modeling of prolactin release following administration of the dopamine D2 receptor antagonists risperidone, paliperidone and remoxipride in rats
We provide the reader with relevant data related to our recently published paper, comparing two mathematical models to describe prolactin turnover in rats following one or two doses of the dopamine D2 receptor antagonists risperidone, paliperidone and remoxipride, “A comparison of two semi-mechanist...
Main Authors: | Amit Taneja, An Vermeulen, Dymphy R.H. Huntjens, Meindert Danhof, Elizabeth C.M. De Lange, Johannes H. Proost |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2016-09-01
|
Series: | Data in Brief |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2352340916304966 |
Similar Items
-
The effects of concurrent oral paliperidone or risperidone use with paliperidone long-acting injection
by: Trevor A. Stump, PharmD, BCPP, et al.
Published: (2021-01-01) -
Valproate, risperidone, and paliperidone: A case of valproate-induced hyperammonemic encephalopathy
by: Kyle Wesselman, PharmD candidate, MA, BS, et al.
Published: (2024-02-01) -
Paliperidone ER and oral risperidone in patients with schizophrenia: a comparative database analysis
by: Schooler Nina, et al.
Published: (2011-02-01) -
Tachycardia during Treatment with Risperidone and Paliperidone Palmitate in a Patient without Previous Cardiovascular Disease
by: Zachary Orlins, et al.
Published: (2021-01-01) -
Effects of Risperidone and Paliperidone on Brain-Derived Neurotrophic Factor and N400 in First-Episode Schizophrenia
by: Rong-Qin Wu, et al.
Published: (2018-01-01)